UNAIDS Calls For More Investment In Female-Controlled HIV Prevention Methods After ‘Encouraging’ Vaginal Ring Trial Results

U.N. News Centre: More investment needed in developing female-controlled HIV prevention options — U.N. agency
“The Joint United Nations Programme on HIV/AIDS (UNAIDS) today welcomed the ‘encouraging’ results of two studies from Africa in which women modestly reduced their risk of infection by inserting a vaginal ring coated with the antiretroviral drug dapivirine once a month. … ‘The results are encouraging and show the urgent need to expand investment in research and development for female-controlled methods of HIV prevention,’ UNAIDS said in a press release…” (2/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.